ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,070.55
      1.20%
      US Tech 100
      17,104.80
      0.60%
      Dow Jones
      38,503.69
      0.69%
      Brent Oil
      87.045
      -0.59%
      Bitcoin
      66,372.65
      -0.06%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC
      6. Rubius Therapeutics Inc (CE) (RUBY)

      7. Rubius Therapeutics Inc (CE) (RUBY) News

      RUBY

      Rubius Therapeutics (CE) (RUBY)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:RUBY
      DateTimeSourceHeadlineSymbolCompany
      04/10/20239:38AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RUBYRubius Therapeutics Inc
      03/09/20237:33AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:RUBYRubius Therapeutics Inc
      03/03/202311:28AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RUBYRubius Therapeutics Inc
      03/02/20238:43AMEdgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:RUBYRubius Therapeutics Inc
      02/27/20238:23AMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:RUBYRubius Therapeutics Inc
      02/27/20237:37AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:RUBYRubius Therapeutics Inc
      02/27/20236:52AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:RUBYRubius Therapeutics Inc
      02/27/20236:50AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:RUBYRubius Therapeutics Inc
      02/27/20236:49AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:RUBYRubius Therapeutics Inc
      02/22/20236:46AMEdgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:RUBYRubius Therapeutics Inc
      02/22/20236:42AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
      02/09/202312:34PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RUBYRubius Therapeutics Inc
      02/06/20234:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
      01/20/20237:33AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RUBYRubius Therapeutics Inc
      12/21/20225:14PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
      12/14/20224:54PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
      12/12/20224:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
      11/02/20224:01PMGlobeNewswire Inc.Rubius Therapeutics Announces Process to Explore Strategic Alternatives and Leadership ChangesNASDAQ:RUBYRubius Therapeutics Inc
      10/13/20224:21PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
      09/19/20228:00AMGlobeNewswire Inc.Rubius Therapeutics to Present at Guggenheim Nantucket Therapeutics ConferenceNASDAQ:RUBYRubius Therapeutics Inc
      09/16/202212:20AMTipRanksAnalysts Have Conflicting Sentiments on These Healthcare Companies: Ascendis Pharma (ASND), Rubius Therapeutics (RUBY) and Connect Biopharma Holdings (CNTB)NASDAQ:RUBYRubius Therapeutics Inc
      09/13/20227:17AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
      09/13/20227:00AMGlobeNewswire Inc.Rubius Therapeutics Announces Strategic UpdateNASDAQ:RUBYRubius Therapeutics Inc
      09/12/20224:30PMGlobeNewswire Inc.Rubius Therapeutics to Provide Strategic UpdateNASDAQ:RUBYRubius Therapeutics Inc
      09/09/202212:40PMTipRanksAnalysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Palatin Technologies (PTN) and Rubius Therapeutics (RUBY)NASDAQ:RUBYRubius Therapeutics Inc
      08/12/20225:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
      08/12/20223:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RUBYRubius Therapeutics Inc
      08/09/202212:35PMTipRanksSVB Securities Keeps Their Hold Rating on Rubius Therapeutics (RUBY)NASDAQ:RUBYRubius Therapeutics Inc
      08/09/20228:18AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RUBYRubius Therapeutics Inc
      08/09/20228:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:RUBY